SP Singh Baghel on Friday took charge as Minister of State (MoS) of Health and Family Welfare. He was moved from the Law Ministry to the Union Ministry of Health and Family Welfare a day before.
After taking charge as MoS of Health and Family Welfare, SP Singh Baghel thanked Prime Minister Narendra Modi for bestowing his trust in him. Baghel, while interacting with the media, assured that he will fulfil all expectations of people.
“I would like to thank Prime Minister Narendra Modi for the expectations, hopes and aspirations that he has given me this new responsibility. I will stand up to what is expected of me with the full support of Mansukh Mandaviya, my colleague Dr Bharati Pravin Pawar and department officials,” said SP Singh Baghel told media persons.
#WATCH | Delhi: SP Singh Baghel takes charge as Minister of State in the Ministry of Health and Family Welfare.
He was shifted to the Ministry of Health and Family Welfare from Ministry of Law and Justice. pic.twitter.com/inRo4YrsQG
— ANI (@ANI) May 19, 2023
Earlier, Union Minister Kiren Rijiju was shifted from the law and justice portfolio to the earth sciences ministry.
Baghel will now act as a deputy of Union Health Minister Mansukh Mandaviya
Baghel will now act as a deputy of Union Health Minister Mansukh Mandaviya, who has been trying hard to bring positive changes in the health sector.
Recently, Mandaviya announced the decision of the Union Cabinet to approve the National Medical Devices Policy 2023. The policy is expected to facilitate a structured growth of the medical device sector to meet the public health objectives of access, affordability, quality, and innovation.
“The policy lays down a roadmap for accelerated growth of the medical devices sector to achieve the objectives of access and universality, affordability, quality, patient centred and quality care, preventive and promotive health, security, research and innovation and skilled manpower,” Health Minister Mansukh Mandaviya had said.
Takeda’s initiatives Aim To Improve Access To Healthcare For Rare Disease patients in India | ALSO READ
The main aim of the policy is to ensure an accelerated growth path with a patient-centric approach and to emerge as the global leader in the manufacturing and innovation of medical devices, by achieving 10-12 per cent share in the expanding global market over the next 25 years, official sources said.
